Patents by Inventor Jack B. Campbell

Jack B. Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Propanamine derivatives
    Patent number: 5135955
    Abstract: Substituted propanamines having anticoagulant or antifungal activity are disclosed. Also disclosed are methods of use involving the substituted propanamines as well as pharmaceutical compositions containing them.
    Type: Grant
    Filed: February 22, 1989
    Date of Patent: August 4, 1992
    Assignee: Eli Lilly and Company
    Inventors: Jack B. Campbell, Gerald F. Smith, William W. Turner
  • Isoquinoline derivatives as immune regulants
    Patent number: 4670442
    Abstract: This invention provides for certain substituted 7H-benzimidazo[2,1-a]benz[de]isoquinoline-7-ones, formulations of the compounds, and a method for their use in suppressing the immune response in mammals.
    Type: Grant
    Filed: August 10, 1983
    Date of Patent: June 2, 1987
    Assignee: Eli Lilly and Company
    Inventors: Jack B. Campbell, Edward R. Lavagnino
  • Preparation of isoquinoline derivatives useful as immune regulants
    Patent number: 4413126
    Abstract: This invention provides for a process of preparing certain trifluoromethyl substituted 7H-benzimidazo[2,1-a]benz[de]isoquinoline-7-ones.
    Type: Grant
    Filed: June 9, 1982
    Date of Patent: November 1, 1983
    Assignee: Eli Lilly and Company
    Inventors: Jack B. Campbell, Edward R. Lavagnino
  • 9-Carbamoyl-9-(2-cyanoethyl)fluorenes
    Patent number: 4282170
    Abstract: 9-Carbamoyl-9-(2-cyanoethyl)fluorenes are intermediates for synthesis of 9-aminoalkyl-9-carbamoyl-fluorenes, which are antiarrhythmic agents.
    Type: Grant
    Filed: April 17, 1980
    Date of Patent: August 4, 1981
    Assignee: Eli Lilly and Company
    Inventors: Edward R. Lavagnino, Andrew J. Pike, Jack B. Campbell
  • Trifluoromethyl dibenzo[a,c]phenazines as immune regulants
    Patent number: 4064127
    Abstract: Novel quinoxaline derivatives, useful as immune regulatory agents capable of altering the immune response in mammals.
    Type: Grant
    Filed: December 23, 1976
    Date of Patent: December 20, 1977
    Assignee: Eli Lilly and Company
    Inventor: Jack B. Campbell
  • Quinoxaline derivatives as immune regulants
    Patent number: 4024142
    Abstract: Novel quinoxaline derivatives, useful as immune regulatory agents capable of altering the immune response in mammals.
    Type: Grant
    Filed: July 16, 1975
    Date of Patent: May 17, 1977
    Assignee: Eli Lilly and Company
    Inventor: Jack B. Campbell
  • Selective dehalogenation
    Patent number: RE28865
    Abstract: An improved process for removal of halogen from the pyrimidine ring only of a compound of the formula ##SPC1##WhereinAt least one of X is chlorine or bromine, the remainder hydrogen; .[.or lower alkyl.].Q is chlorine or fluorine; andN is an integer from 1 to 5.The dehalogenation process yields an .alpha.-halophenyl-.alpha.-phenyl-5-pyrinidylmethane of 95 percent or higher purity, which compound is useful as an intermediate in the preparation of the corresponding .alpha.-halophenyl-.alpha.-phenyl-5-pyrinidylmethanol, useful as an agricultural fungicide.
    Type: Grant
    Filed: July 30, 1975
    Date of Patent: June 15, 1976
    Assignee: Eli Lilly and Company
    Inventor: Jack B. Campbell